HPV-18 E6*I modulates HPV-18 full-length E6 functions in a cell cycle dependent manner

International Journal of Cancer

Volumn 110, Issue 6, 2004, Pages 928-933

  Guccione, Ernesto ^a   Pim, David ^a   Banks, Lawrence ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Cell cycle; E6; E6*I; HPV; Proteasome degradation

Indexed keywords

CELL PROTEIN; EPITOPE; PROTEASOME INHIBITOR; PROTEIN E6; PROTEIN E6 I; PROTEIN HDLG; PROTEIN P53; SCRIBBLE PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL FRACTIONATION; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; VIRUS STRAIN; WART VIRUS;

CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; FLOW CYTOMETRY; HUMANS; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; PAPILLOMAVIRIDAE; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 2942621870     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20184     Document Type: Article

References (29)

1. Hoppe-Seyler F, Butz K, zur Hausen H. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J Virol 1991;65:5613-8.
2. de Villiers EM. Papillomavirus and HPV typing. Clin Dermatol 1997;15:199-206.
3. zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999;111:581-7.
4. Kanda T, Furuno A, Yoshiike K. Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J Virol 1988;62:610-3.
5. Vousden KH, Doniger J, DiPaolo JA, Lowy DR. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Oncogene Res 1988;3:167-75.
6. Sedman SA, Barbosa MS, Vass WC, Hubbert NL, Haas JA, Lowy DR, Schiller JT. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J Virol 1991;65:4860-6.
7. Bedell MA, Jones KH, Grossman SR, Laimins LA. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J Virol 1989;63:1247-55.
8. Jones DL, Alani RM, Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 1997;11:2101-11.
9. Song S, Liem A, Miller JA, Lambert PF. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 2000;267:141-50.
10. Chow LT, Reilly SS, Broker TR, Taichman LB. Identification and mapping of human papillomavirus type 1 RNA transcripts recovered from plantar warts and infected epithelial cell cultures. J Virol 1987;61:1913-8.
11. Smotkin D, Wettstein FO. Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci USA 1986;83:4680-4.
12. Schneider-Gadicke A, Schwarz E. Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 1986;5:2285-92.
13. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111-4.
14. Shally M, Alloul N, Jackman A, Muller M, Gissmann L, Sherman L. The E6 variant proteins E6I-E6IV of human papillomavirus 16: expression in cell free systems and bacteria and study of their interaction with p53. Virus Res 1996;42:81-96.
15. Doorbar J, Parton A, Hartley K, Banks L, Crook T, Stanley M, Crawford L. Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line. Virology 1990;178:254-62.
16. Schneider-Gadicke A, Kaul S, Schwarz E, Gausepohl H, Frank R, Bastert G. Identification of the human papillomavirus type 18 E6 and E6 proteins in nuclear protein fractions from human cervical carcinoma cells grown in the nude mouse or in vitro. Cancer Res 1988;48:2969-74.
17. Stacey SN, Jordan D, Snijders PJ, Mackett M, Walboomers, JM, Arrand JR. Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. J Virol 1995;69:7023-31.
18. Pim D, Banks L. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 1999;18:7403-8.
19. Pim D, Massimi P, Banks L. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth. Oncogene 1997;15:257-64.
20. Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S, Axel R. Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 1979;16:777-85.
21. Guccione E, Massimi P, Bernat A, Banks L. Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins. Virology 2002;293:20-5.
22. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 1999;9:379-86.
23. Kehmeier E, Ruhl H, Voland B, Stoppler MC, Androphy E, Stoppler H. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 2002;299:72-87.
24. Reinstein E, Scheffner M, Oren M, Ciechanover A, Schwartz A. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 2000;19:5944-50.
25. Fagioli M, Alcalay M, Pandolfi PP, Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F, Pelicci PG. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene 1992;7:1083-91.
26. Nilsson CH, Bakos E, Petry KU, Schneider A, Durst M. Promoter usage in the E7 ORF of HPV16 correlates with epithelial differentiation and is largely confined to low-grade genital neoplasia. Int J Cancer 1996;65:6-12.
27. Bohm S, Wilczynski SP, Pfister H, Iftner T. The predominant mRNA class in HPV16-infected genital neoplasias does not encode the E6 or the E7 protein. Int J Cancer 1993;55:791-8.
28. Pim D, Thomas M, Javier R, Gardiol D, Banks L. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 2000;19:719-25.
29. Goodwin EC, DiMaio D. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 2000;97:12513-8.